Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovative and...
Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. announced a strategic collaboration to increase patient access to...
Company Leverages Causal Machine Learning to Overcome Key Challenges in Developing New Cancer Treatments
PhaseV, a pioneer in software and machine learning (ML) for clinical...
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024
CluePoints, provider of leading...
This strategic acquisition combines BioCentric's medical affairs and commercial expertise with JPA Health's integrated services, predictive analytics and AI-driven solutions
JPA Health, a global full-service,...
Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary AI and machine learning (ML) platform, RADR®,...
Multicenter EXCYTE-2 Study to Evaluate the Precision Medicine Platform in Patients With Acute Myeloid Leukemia
Exscientia plc announced the launch of EXCYTE-2, an observational clinical...